The US Food and Drug Administration (FDA) classified this as a Class 1 recall, meaning the product posed a serious health ...
X4 Pharmaceuticals is laying off 30% of its staff and halting preclinical R&D as the immune system specialist channels its resources into recently approved rare disease drug mavorixafor.
The White House is drafting an executive order to lay off thousands of employees from the Department of Health and Human ...
Hosted on MSN23h
Walmart recalls full list: Lay’s chips, meds and more—are any in your home right now?An estimated 15 million Americans have food allergies, which result in 30,000 ED visits and 150–200 fatalities annually ...
Nearly one year after winning an FDA drug approval to treat an ultra-rare disease, X4 Pharmaceuticals is making layoffs that ...
CBS News Philadelphia found out Jet Rescue Air Ambulance had another plane crash 15 months ago in Mexico. A federal official ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback